2025年3月21日 · BCG treatment is the main immunotherapy used to treat early-stage bladder cancer. With BCG treatment, your healthcare provider places medication directly inside of your …

BCG is for: Early-stage bladder cancer. This is cancer that is only in the bladder’s lining, and is stage 0 or stage 1. Bladder cancer that is not in the muscle of the bladder’s wall (non-muscle …

2025年3月20日 · Based on the current understanding of BCG’s therapeutic principles and resistance mechanisms, we systematically explore strategies to improve BCG-based tumor …

2023年6月5日 · Bacillus Calmette Guerin (BCG), a type of intravesical immunotherapy, helps the immune system destroy cancer cells and is often used to treat early-stage bladder cancer. …

BCG cancer therapy began to be used and studied in 1930, and from this, its antitumor effect was demonstrated in clinical and laboratory trials in malignant cell lines [4,5,6,7]. Morales and …

2020年9月1日 · Over 30 years’ successful application of Bacillus Calmette Guerin (BCG) to the clinical treatment of bladder cancer has proved it one of the most promising immunotherapies …

Physicians treating patients affected by nonmuscle-invasive bladder cancer (NMIBC) have been in shock during the last six years since manufacturing restrictions on the production of the first …

2025年2月11日 · For several decades, intravesical Bacillus Calmette–Guérin (iBCG) immunotherapy has been the gold standard adjuvant treatment for high-risk and selected …

Bacillus Calmette-Guérin (BCG) is the standard immune therapy for non-muscle invasive bladder cancer. A systematic review of published articles regarding BCG treatment of bladder cancer …

2014年2月4日 · Despite long clinical experience with BCG, the mechanism of its therapeutic effect is still under investigation. Available evidence suggests that urothelial cells (including bladder …